Press Releases

NEW YORK, Dec. 5, 2019 /PRNewswire/ -- Edwards Lifesciences Corporation (NYSE: EW), the global leader in patient-focused innovations for structural heart disease and critical care monitoring, will discuss the company's strategy for longer-term growth, provide an update on its technology pipeline and share its financial guidance during its annual investor conference today

BIRMINGHAM, Ala., Dec. 5, 2019 /PRNewswire/ -- Encompass Health Corp. (NYSE: EHC) today announced it will participate in the 38th Annual J.P. Morgan Healthcare Conference being held Jan. 13-16, 2020, in San Francisco, California.

STOCKHOLM, Dec. 5, 2019 /PRNewswire/ -- Sobi™ and its wholly owned subsidiary Dova Pharmaceuticals, will present new data from studies with avatrombopag for the treatment of thrombocytopenia in adult patients with chronic liver disease (CLD) as well as patients with chronic immune thrombocytopenia (ITP) at the 61st Annual Meeting of the American Society of Hematolo

DALLAS, Dec. 5, 2019 /PRNewswire/ -- Jane Sarasohn-Kahn

NEW YORK and WELLESLEY, Mass., Dec. 5, 2019 /PRNewswire/ -- Harvard Pilgrim Health Care and Ride Health have announced a collaboration to offer non-emergency medical transportation at no cost for Medicare Advantage members in Massachusetts and New Hampshire.

TORONTO, Dec. 5, 2019 /PRNewswire/ - ACTO achieved 158% year to date revenue growth and has digitally transformed over 50 life sciences companies, including global pharma, medical device, and dental companies. Since its launch one year ago, the ACTO Commercialization Cloud for Life Sciences has digitally transformed companies such as AstraZeneca, Teleflex, and Philips Re

TARRYTOWN, N.Y., Dec. 5, 2019 /PRNewswire/ --Results from initial 6-patient cohort show pozelimab reduced lactate dehydrogenase (LDH) to normal levels at week 8 in patients with paroxysmal nocturnal hemoglobinuria (PNH), utilizing a weekly subcutaneous dosing regimen Second part of Phase 2 trial initiated; plans for Phase 3 program underway

NEW YORK, Dec. 5, 2019 /PRNewswire/ -- pCare™ has entered a new partnership with

WHIPPANY, N.J., Dec. 5, 2019 /PRNewswire/ -- Bayer announced today that it has entered into a three-year collaboration agreement with Children's Hospital of Philadelphia (CHOP) for the discovery and development of small molecules (SMOLs) to develop a first-in-class oral non-replacement therapy (NRT) for the treatment of hemophilia A

TEL AVIV, Israel, Dec. 5, 2019 /PRNewswire/ -- BioLineRx Ltd. (NASDAQ: BLRX) (TASE: BLRX), a clinical-stage biopharmaceutical company focused on oncology, announced today preliminary data from the triple combination arm of the ongoing Phase 2a COMBAT/KEYNOTE-202 study showing that the combination of BL-8040 (a CX